BGB Rejects Natraceutical Call
Bio Group Brazil (BGB) says it has rejected a call option on a 46.8% stake in Natraceutical, valued at EUR66m. BGB received...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.